Browse studies

Find your next paid study

3,847 recruiting studies matching your filters

A Phase 2A, Prospective, Open Label, Single Institution Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)

The main purpose of this study is to gather information about an investigational drug combination, Lenvatinib in combination with pembrolizumab, that may help …

Cervix CancerCervical Cancer

Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT06266338

African Cancer Genome Cohort to Promote Health Equity Among Patients of African Ancestry: Characterization of Genetic and Molecular Drivers

The goal of this study is to develop a comprehensive characterization of genetic and molecular drivers of breast and prostate cancer in individuals of African …

Breast CancerProstate Cancer

Estimated

~$10 – $750

Fox Chase Cancer CenterNCT05754658

Observational

A Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

This study aims to assess the safety and clinical accuracy of the SIRA-1000, SIRA® RFA Electrosurgical Device in ablating margins post-lumpectomy in patients u…

Breast CancerBreast-conserving SurgeryBreast Cancer - Infiltrating Ductal Carcinoma+2 more

Estimated

~$10 – $8,750

Innoblative Designs, Inc.NCT07206121

Circulating HPV DNA in Cancers of the Anus and Uterine Cervix Treated With Definitive Radiation Therapy

This is a research study for individuals who have cancer associated with human papillomavirus (HPV) and are being treated with radiation as part of standard ca…

Cervical CancerAnal CancerHPV-Related Anal Squamous Cell Carcinoma+3 more

Estimated

~$10 – $750

University of ChicagoNCT04857528

Phase 1

Biomarker Driven Phase 1/1b Trial of Decitabine and Nivolumab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

This research study is for people who have recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) that has been confirmed by tissue or cell anal…

Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma

Estimated

~$10 – $7,500

Kyunghee Burkitt, DO, PhDNCT07216833

Phase 1

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Randomized phase 2, multicenter, biomarker directed clinical trial with a safety lead-in to assess the efficacy of Stenoparib plus Temozolomide (TMZ) in relaps…

Relapsed Small Cell Lung CancerRecurrent Small Cell Lung Cancer

Estimated

~$10 – $5,625

VA Office of Research and DevelopmentNCT06681220

Phase 2

A Phase 2 Evaluation of the Safety and Efficacy of Veonetinib (AL8326) in ≥2nd Line Small Cell Lung Cancer (SCLC), Non Small Cell Lung Cancer (NSCLC) and Renal Cell Carcinoma (RCC) Treatment

This trial is a Phase II trial designed to evaluate the safety and efficacy of using oral AL8326 , a multi-targeted receptor Tyrosine Kinase Inhibitor( TKI) , …

Small Cell Lung CancerRenal Cell Carcinoma (RCC)Non-Small Cell Lung

Estimated

~$10 – $8,750

Advenchen Pharmaceuticals, LLC.NCT05363280

A Pilot Study Evaluating the Feasibility of Novel MRI Sequences and Blood-Based Biomarkers for Discriminating Nodules Found During Lung Cancer Screening

The primary objective of this pilot observational study is to evaluate the accrual and retention rate of a study population from a centralized lung cancer scre…

Lung Cancer

Estimated

~$10 – $750

Cedars-Sinai Medical CenterNCT05699213

Observational

High-dose Rate (HDR) Brachytherapy Boost With Stereostatic Body Radiation Therapy (SBRT) to Prostate and Pelvic Nodes for the Initial Treatment of Unfavorable Intermediate or Higher Risk Prostate Cancer

The objective of this phase I/II trial is to prospectively evaluate the toxicity and therapeutic efficacy of Stereostatic Body Radiation Therapy (SBRT) to pros…

Prostatic Cancer

Estimated

~$10 – $6,250

University of NebraskaNCT05754580

Phase 2

A Phase 2 Risk Adapted Parallel Randomized Trial of MRI-Guided Lattice Stereotactic Focal Radiotherapy of the Prostate With or Without Ultra-Short Term Androgen Deprivation Therapy-The Miami UAdapt Trial

The purpose of this prostate cancer research study is to investigate: 1. For early-stage patients, the use of a single session of high dose stereotactic body …

Prostate Cancer

Estimated

~$10 – $6,250

University of MiamiNCT06111313

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System

The purpose of this study is to evaluate the short and intermediate term safety of the NanoKnife Irreversible Electroporation System when used off-label to tre…

Pancreatic Cancer Non-resectable

Estimated

~$10 – $750

Englewood Hospital and Medical CenterNCT06937996

Observational

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

The purpose of this research is to determine whether a 16-week virtually supervised aerobic and resistance exercise program is feasible in patients receiving f…

Ovarian CancerOvarian CarcinomaOvarian Cancer Stage IV+4 more

Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT04997096